Kesem Health announces its launch of iUFlow XL™, a bladder monitoring platform with Extended Battery Life (XL)
Announcement posted by KESEM HEALTH PTY LTD 19 May 2021
Melbourne, Australia – 20 May 2021: Kesem Health, a digital health company that launched the market leading bladder diary and a home bladder monitoring platform, iUFlow, today announces the launch of iUFlow XL™ (Extended Life) on their website and their Amazon storefront.
Patients suffering from Lower Urinary Tract Symptoms (LUTS) are often required to complete a bladder diary and in some cases perform a uroflowmetery test in the urology clinic. Kesem Solutions’ iUFlow™ rated for 120 urinations or up to 6 weeks, delivers the perfect solution for these patients. “Patients who are undergoing a PTNS (Percutaneous Tibial Nerve Stimulation) or Sacral nerve stimulation (SNS) may require a longer period of monitoring with a frequency over ten voids a day and this is where iUFlow XL is perfectly positioned”, says Gil Hidas, CEO of Kesem Health.
Stephen Wilson, VP of Sales and Marketing, adds “the iUFlow XL targets unmet needs of patients and providers who both requested a longer period of time for low cost bladder monitoring @ Home”.
Kesem Health’s platform includes the world’s leading free voiding App, the smart sensor and a secure web based portal to accurately and wirelessly measure urine flow, volume and frequency. The iUFlow™ app is available on both Apple and Android smartphones today.
About Kesem Health
Kesem Health is a Melbourne based digital health company devoted to improving the convenience and accuracy of remote bladder monitoring for the diagnosis and management of urological conditions. Kesem’s iUFlow™ platform is patented and approved with FDA, TGA, and CE Marks.